Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
about
Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe.Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid ArthritisA Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise StudyPatient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe.Using Patient Feedback to Optimize the Design of a Certolizumab Pegol Electromechanical Self-Injection Device: Insights from Human Factors Studies.Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis.Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability.Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover studyPatients' and nurses' preferences for autoinjectors for rheumatoid arthritis: results of a European survey
P2860
Q27335007-5B097D41-5688-4FEE-A868-4F8AA685E207Q33725535-89FA3669-88B7-4F6B-8312-31CB0F340531Q36205494-475C2C5D-2CCA-4639-9FA6-85067ACFDE80Q37453045-08165B2C-DE8C-49A1-AFA8-39D48BFC54E4Q47266821-89AB4175-3CE5-4F42-A66A-EC8EC638557CQ47325125-81760491-FEEA-42D9-956F-920B902908F0Q54956831-F8FFC4F7-78E4-4843-81A2-CFB11AD7A59FQ57176982-01D6A3E1-017D-42D8-B58B-61C169D34D54Q58803517-5797C015-57AE-4296-A386-A087B0DD4F03
P2860
Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Subcutaneously administered me ...... the self-injection experience.
@ast
Subcutaneously administered me ...... the self-injection experience.
@en
Subcutaneously administered me ...... the self-injection experience.
@nl
type
label
Subcutaneously administered me ...... the self-injection experience.
@ast
Subcutaneously administered me ...... the self-injection experience.
@en
Subcutaneously administered me ...... the self-injection experience.
@nl
prefLabel
Subcutaneously administered me ...... the self-injection experience.
@ast
Subcutaneously administered me ...... the self-injection experience.
@en
Subcutaneously administered me ...... the self-injection experience.
@nl
P2093
P2860
P356
P1476
Subcutaneously administered me ...... the self-injection experience.
@en
P2093
Anke Liebhaber
Cécile Guimbal-Schmolck
Georg Hübner
Holger Schwenke
Karin Rockwitz
Peter Kästner
Ulrich Schoo
Uwe Pichlmeier
Winfried Demary
P2860
P304
P356
10.2147/PPA.S64111
P407
P577
2014-08-06T00:00:00Z